BioMed Central cancer
-
- Visão geral
-
- Metrics
-
- Identidade
-
- Informação adicional documento
-
- Ver todos
-
Visão geral
Qualis
código do país
tipo
publicação venue de
-
A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait.
23:1-556.
2023-01-01
-
Elemental profiles in distant tissues during tumor progression.
23:1-10.
2023-01-01
-
Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
23:613.
2023-01-01
-
A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease.
22:1-1063.
2022-01-01
-
Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology.
22:1-1.
2022-01-01
-
Muscle strength is associated with fracture risk obtained by fracture risk assessment tool (FRAX) in women with breast cancer.
22:1-12.
2022-01-01
-
Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
22:706.
2022-01-01
-
Public procurement of antineoplastic agents used for treating breast cancer in Brazil between 2013 and 2019.
1:769.
2022-01-01
-
Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib.
22:625.
2022-01-01
-
Relationship between time from symptom?s onset to diagnosis and prognosis in patients with symptomatic colorectal cancer.
22:910.
2022-01-01
-
Serum 25-Hydroxyvitamin D and Cancer-Related Fatigue: Associations and Effects on Depression, Anxiety, Functional Capacity and Health-Related Quality of Life in Breast Cancer Survivors During Adjuvant Endocrine Therapy.
22:2-20.
2022-01-01
-
Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
22:1-23.
2022-01-01
-
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
22:1108.
2022-01-01
-
The oncological safety of autologous fat grafting: a systematic review and meta-analysis.
22:391.
2022-01-01
-
Three-dimensional nuclear telomere architecture and differential expression of aurora kinase genes in chronic myeloid leukemia to measure cell transformation.
22:1024.
2022-01-01
-
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
21:901.
2021-01-01
-
A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
21:21(1):861.
2021-01-01
-
Anti-proliferative and pro-apoptotic activity of glycosidic derivatives of lawsone in melanoma cancer cell.
21:1-13.
2021-01-01
-
Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
21:480.
2021-01-01
-
Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort.
21:525.
2021-01-01
-
Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
21:1-8.
2021-01-01
-
Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
21:811-811.
2021-01-01
-
ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
21:1-10.
2021-01-01
-
Integrative analysis of mRNA and miRNA profiles identifies miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
21:1-76.
2021-01-01
-
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
21:575-585.
2021-01-01
-
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
21:193.
2021-01-01
-
Olaparib-mediated enhancement of 5-fluorouracil cytotoxicity in mismatch repair deficient colorectal cancer cells.
21:21(1):448-461.
2021-01-01
-
Race disparities in mortality by breast cancer from 2000 to 2017 in São Paulo, Brazil: a population-based retrospective study.
21:1-8.
2021-01-01
-
Salivary cytokines as biomarkers of oral cancer: a systematic review and meta-analysis.
21:1-16.
2021-01-01
-
Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma..
1:1-13.
2021-01-01
-
The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
21:1-1268.
2021-01-01
-
The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma.
21:1-11.
2021-01-01
-
The role of education on Cancer amenable mortality among non-Hispanic blacks & non-Hispanic whites in the United States (1989-2018).
21:1-20.
2021-01-01
-
Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
21:682-682.
2021-01-01
-
Transcriptional landscape of PTEN loss in primary prostate cancer.
21:856.
2021-01-01
-
1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
20:869.
2020-01-01
-
3?UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
20:1-7.
2020-01-01
-
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy.
19:1173-1184.
2020-01-01
-
CYP19A1 gene expression in the peripheral blood of Brazilian women with breast cancer relapse.
20:01-487.
2020-01-01
-
Cancer cases and deaths attributable to lifestyle risk factors in Chile.
20:693-707.
2020-01-01
-
Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
20:843.
2020-01-01
-
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients.
20:1-10.
2020-01-01
-
Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
20:1-14.
2020-01-01
-
Expression of the NEK family in normal and cancer tissue: an immunohistochemical study.
20:1-13.
2020-01-01
-
Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.
20:821.
2020-01-01
-
Intranasal perillyl alcohol therapy improves survival of patients with recurrent glioblastoma harboring mutant variant for MTHFR rs1801133 polymorphism.
20:1-10.
2020-01-01
-
Multiple formin proteins participate in glioblastoma migration.
20:710.
2020-01-01
-
Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients..
20:1-1042.
2020-01-01
-
P16 as a marker of carcinoma in effusions and peritoneal washing.
20:1-234.
2020-01-01
-
PDAC-ANN: an artificial neural network to predict pancreatic ductal adenocarcinoma based on gene expression.
20:1-11.
2020-01-01
-
Potential biomarkers of ductal carcinoma in situ progression.
20:1-127.
2020-01-01
-
Preoperative Differentiation of Benign and Malignant Non-epithelial Ovarian Tumors: Clinical Features and Tumor Markers..
42:555-561.
2020-01-01
-
Presence of dynapenia and association with anthropometric variables in patients with cancer.
20:'-9.
2020-01-01
-
Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
20:1-10.
2020-01-01
-
Skin pigmentation polymorphisms associated with increased risk of melanoma in a case-control sample from southern Brazil.
20:1-15.
2020-01-01
-
Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
20:1-11.
2020-01-01
-
miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
20:1-153.
2020-01-01
tem uma área de assunto
publisher
is open access
-
True
invalid format
is in DOAJ
-
True
invalid format
Metrics
2 year mean citedness
H index
i10 index
Identidade
ISSN-L
openalex identifier
-
https://openalex.org/S192926780
International Standard Serial Number (ISSN)